ComPAS: A Bayesian drug combination platform trial design with adaptive shrinkage

2018 ◽  
Vol 38 (7) ◽  
pp. 1120-1134 ◽  
Author(s):  
Rui Tang ◽  
Jing Shen ◽  
Ying Yuan
Keyword(s):  
Drug Combination ◽  
Trial Design ◽  
Adaptive Shrinkage

Phase I Drug Combination Trial Design: Walking the Tightrope

2009 ◽  
Vol 27 (27) ◽  
pp. 4441-4443 ◽  
Author(s):  
Paul Hamberg ◽  
Jaap Verweij
Keyword(s):  
Phase I ◽  
Drug Combination ◽  
Trial Design

Author response for "Clinical trial risk in leukemia: Biomarkers and trial design"

2020 ◽  
Author(s):  
Alice J. Li ◽  
Jasper P. Dhanraj ◽  
Gilberto Lopes ◽  
Jayson L. Parker
Keyword(s):  
Clinical Trial ◽  
Trial Design ◽  
Author Response

Rationale and trial design of the Left Atrial Appendage Occlusion Study (LAAOS III)

2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
W. Reents ◽  
A. Diegeler ◽  
J. Babin-Ebell ◽  
A. Böning ◽  
R.P. Whitlock
Keyword(s):  
Left Atrial ◽  
Trial Design ◽  
Left Atrial Appendage ◽  
Atrial Appendage ◽  
Left Atrial Appendage Occlusion

1295-P: Economic Evaluation of Drug Combination Strategy for Type 2 Diabetes in China

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1295-P
Author(s):  
SHUYAN GU ◽  
YI SHEN ◽  
LIZHENG SHI ◽  
HENGJIN DONG
Keyword(s):  
Type 2 Diabetes ◽  
Economic Evaluation ◽  
Drug Combination ◽  
Combination Strategy

Integrating radiomics into clinical trial design

2019 ◽  
Vol 63 (4) ◽  
Author(s):  
Jessica J. Waninger ◽  
Michael D. Green ◽  
Catherine Cheze Le Rest ◽  
Benjamin Rosen ◽  
Issam El Naqa
Keyword(s):  
Clinical Trial ◽  
Trial Design ◽  
Clinical Trial Design

Rosuvastatin and ezetimibe – the optimal drug combination

2020 ◽  
Vol 13 (2) ◽  
pp. 171-172
Author(s):  
Krzysztof J. Filipiak
Keyword(s):  
Drug Combination ◽  
Optimal Drug
Sign in / Sign up

Export Citation Format

Share Document